Previous Close | 10.90 |
Open | 10.90 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 300.00 |
Expire Date | 2026-01-16 |
Day's Range | 10.90 - 10.90 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Styker's flagship, Mako Total Knee Platform, its strategic acquisitions and a diversified product portfolio raise optimism about the stock.
Stryker completes the acquisition of Vertos Medical to expand its interventional pain management solutions.
Portage, Michigan, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report its third quarter 2024 financial results on Tuesday, October 29, 2024. A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the quarter ended September 30, 2024. Stryker will host a webcast at 4:30pm ET on Tuesday, October 29, to discuss results for the third quarter. The web